National Oncology Prize
The Echevarne Foundation rewards the scientific effort that has most contributed to developing our knowledge of cancer genomes, their alterations, transcriptomes and/or epigenomes and their functional interpretation in cell transformation and/or tumour progression, including metastatic dissemination. The Prize consists of a sum of 50,000€ that is awarded to a single researcher for their scientific results.
WINNER OF THE 7TH ECHEVARNE FOUNDATION NATIONAL ONCOLOGY PRIZE
Dr. Elías Campo, awarded the prize for his research on the genetics and molecular biology of human leukaemia
The Echevarne Foundation has awarded its annual prize to Dr. Elías Campo, a Spanish pathologist and researcher, for his work in the field of the genetics and molecular biology of human leukaemia. He is considered a pioneer and international leader in research into lymphocytic leukaemia and mantle cell lymphoma, and the work done by his laboratory, alongside projects in collaboration with other national and international researchers, has managed to decipher the genome of the disease, making it possible to make progress with its diagnosis.
For more information:
Tel. +34 935 059 758
History of the National Oncology Prize
Historia del Premio
1st Echevarne Foundation National Oncology Prize
In 1995 the winner of the Echevarne Foundation National Oncology Prize was Dr. Carlos López-Otín for his work “Identificación y caracterización estructural y funcional de nuevos enzimas proteolíticos e inhibidores de proteasas asociados a carcinomas mamarios”.
5th Echevarne Foundation National Oncology Prize
The Echevarne Foundation presented its 5th National Oncology Prize to Dr. Eugenio Santos, director of the National Cancer Centre and the person to discover the first oncogene in human tumours.
4th Echevarne Foundation National Oncology Prize
Awarded in a special edition to recognise the work of transnational research in molecular and clinical oncology, on this occasion, the prize was awarded ex-aequo to Professors Emili Montserrat and Jesús F. San Miguel for their respective works: “La proteína ZAP-70 como algoritmo terapéutico en leucemia linfática crónica” and “La biología celular del mieloma y sus aplicaciones en el tratamiento de mieloma múltiple”.
Professor Jesús F. San Miguel holds a degree in Medicine from the University of Navarra and a Doctorate from the University of Salamanca. He is currently Professor of Medicine at this University, Head of Haematology at the University Hospital of Salamanca and Deputy Director of the Cancer Research Centre of the same city. He is a founding member of the European Myeloma Network and the Scientific Committee of the International Myeloma Foundation and Multiple Myeloma Research Foundation. He has recently been distinguished with the Waldenstrom Award for his research in this field.
3rd Echevarne Foundation National Oncology Prize
In 2003, a special third edition of the Prize was held, coinciding with the 10th Anniversary of the Echevarne Foundation, with the winners being ex-aequo Drs. Xosé Bustelo and Manuel Serrano for their respective works “Caracterización funcional de la familia de oncoproteínas Vav” and “Mecanismos de supresión tumoral en respuesta al estrés oncogénico”.
Dr. Manuel Serrano has a degree in Biology from the Autonomous University of Madrid and a doctorate in the same specialty from the Severo Ochoa Molecular Biology Centre of the Higher Council for Scientific Research. He completed postdoctoral studies at the Cold Spring Harbor Laboratory (NY) under the direction of Dr. David Leach. He currently directs a research group at the National Centre for Oncological Research in Madrid.
2nd Echevarne Foundation National Oncology Prize
The second Prize was awarded in 1999 to Dr. María A. Blasco for her work on the “Implicación de la telomerasa y los telomeros en inestabilidad cromosómica y cáncer”.
6th Echevarne Foundation National Oncology Prize
The Echevarne Foundation awarded the 6th National Oncology Prize to Dr. Manel Esteller, Director of the Cancer Epigenetics and Biology Programme of the Bellvitge Biomedical Research Institute (IDIBELL) and Head of the Cancer Epigenetics Group, as well as Professor of Genetics at the University of Barcelona School of Medicine and ICREA Research Professor.